Scilex Holding Company

11/12/2024 | Press release | Distributed by Public on 11/12/2024 18:57

Scilex Bio, a Controlling Interest of Joint Venture by Scilex Holding Company, Reports KDS2010 a Novel Oral Tablet Phase 2 Trial for Alzheimer’s Disease (AD) Currently[...]

Read this content
Click here to read the original version at the source's official website. The text of this article is not available at the moment.